Table 2.
Case | Area injected + halo | Hemisphere injected | Tracer | Volume injected (μl) | Injection area (mm2) | Injection RF | Figure number |
---|---|---|---|---|---|---|---|
13-114 | S1 body | Left | FR | 0.2 | 0.07 | 6 | |
12-13* | S1 body | Right | FR | 0.3 | 0.11 | 7 | |
13-126 | S1 face | Left | FR | 0.2 | 0.07 | Face/Vib | 2, 8 |
09-18* | S1 face | Left | FR | 0.3 | 0.07 | ||
12-18* | S1 | Right | FR | 0.3 | 0.06 | Vib/Forepaw | 9 |
13-73 | S1 | Right | FE | 0.3 | 0.07 | ||
08-29* | SC | Left | FE | 0.3 | 0.08 | 10 | |
09-18* | SC | Left | FE | 0.3 | 0.14 | ||
13-73 | SC | Right | FR | 0.2 | 0.12 | 11 | |
08-80* | MM | Left | FE | 0.3 | 0.07 | Unresponsive | 12 |
08-80* | SR | Left | FR | 0.3 | 0.07 | Lips | 13 |
13-126 | S1 body, SR | Left | CTB | 0.15 | 1.03 | Forepaw | 2 |
Receptive field of injection site is shown, when available.